Morning Read: Valeant wants to buy Sprout in $1B deal, Allscripts and CoverMyMeds collaborate
Valeant Pharmaceuticals is making a $1 billion pitch for Sprout Pharmaceuticals which received FDA approval for a women's libido enhancing drug.
Sprout Pharmaceutials